PS-102
Hematological Malignancies
PreclinicalActive
Key Facts
About Perimeter Systems, Inc.
Developing precision gene therapy delivery platforms for oncology with enhanced tumor targeting and reduced off-target effects.
View full company profileTherapeutic Areas
Other Hematological Malignancies Drugs
| Drug | Company | Phase |
|---|---|---|
| NP-G2-044 | Novita Pharmaceuticals | Phase 2a |
| JaxBio Hematology Cancer Test | JaxBio | Preclinical |